🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

肥満のHFpEFでセマグルチド投与群でループ利尿薬が減ったという報告！

重症心不全患者への在宅静注強心薬持続投与指針が発表になりました｜ニュース｜医療法人社団ゆみの yumino-medical.com/news/2024/03/0…

Great discussions from experts around the world. There’s no boundaries for seeking better health!

なぬっ！？

#FINEARTSHF has studied pts w HF & LVEF≥40% so will only be applicable to #HFmrEF/#HFpEF #FINALITYHF however will study finerenone vs PBO in n=2,600 pts w #HFrEF intolerant to a steroidal MRA #MOONRAKER program to summarize the totality of evidence across the #LVEF spectrum 👇🏾

European Society of Cardiology #ESC2024 London 🔥 HOTLINE 🔥 sessions announced Don’t miss what’s new in MRA in HF scottdavidsolomon presents FINEARTS-HF First of MOONRAKER program Muthu Vaduganathan presents pooled analysis of finerenone in HF cohort from CKD trials (FIDELIO/FIGARO) Mikhail Kosiborod

HFpEFに新たな希望！non steroidal MRAです！Finerenone meets primary endpoint in Phase III FINEARTS-HF cardiovascular outcomes study in patients with heart failure with mildly reduced or preserved ejection fraction bayer.com/media/en-us/fi…

My mentee’s first presentation at international congress #ESC2024! Well done! So proud of him! ⁦Yuto Miura⁩

Very important data and great discussion from the Cannulae TAVR study! 海外とのコラボ研究ができるのは本当にすごい！どれだけ陰で努力しているんだろう。。。尊敬しかないです⁦Yohei Turi Ohno⁩ #ESC2024

Original Article: Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (FINEARTS-HF) nej.md/470x4ix #ESCardio | European Society of Cardiology

BREAKING NEWS The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

待ちに待ったSOUL試験のトップライン結果-経口GLP1受容体作動薬のリベルサスでMACE14%有意に減少！ novonordisk.com/news-and-media…

Mission impossible でざわめいたこの一週間で分かった循環器分野における翻訳能力;専門の医師＞ネイティブ＞専門外の医師＞ChatGPT＞プロの翻訳者＞大学生＞DeepL。 日本語は難しい、、、

私が尊敬する三重大学の坂東泰子教授より拡散依頼です。 2月22日(土)Go Red for Women Japan の健康セミナーが開催されます。男性でも一般の方でもどなたでも無料で参加可能です！ 今回は初めての関西開催。ゲストには元サッカー日本代表の澤穂希さん！ grfw-j.j-circ-assoc.or.jp

The FXI inhibitor abelacimab substantially lowers bleeding compared with rivaroxaban in AF patients in the recently published AZALEA-TIMI 71 trial, out now in NEJM Robert Giugliano Sid M. Patel nejm.org/doi/full/10.10…

Glad to share our latest study from OCEAN-Mitral OCEAN-SHD. Hope this study will guide physicians who are involved in this field. Will discuss #MTEER × #TR more at #PCRTokyo PCRonline 🫀 next weekend! Don’t miss it!

Here we go! Evolut low risk trial 5 yrs result. Lot’s of discussion going on… obviously we need longer term follow-up but still the results are promising with this platform. 今年は日循と丸かぶりでしたが、オンラインで参加したLBCTはなかなか盛り上がってましたよ！是非ご覧ください。

Thanks for sharing Muthu! It was a huge team effort.

Beautiful reflection on kintsugi.The idea that our cracks & failures can become sources of wisdom and to find transformation in brokenness, not disposal challenges healthcare's perfectionist culture. Beautiful to see someone from outside Japan embrace this philosophy! 必読です！